{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:16:34Z","timestamp":1791983794336,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390857198"],"award-info":[{"award-number":["390857198"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS109209"],"award-info":[{"award-number":["NS109209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS099328"],"award-info":[{"award-number":["NS099328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS121826"],"award-info":[{"award-number":["NS121826"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS122880"],"award-info":[{"award-number":["NS122880"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS133979"],"award-info":[{"award-number":["NS133979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.tins.2024.05.005","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T14:53:41Z","timestamp":1718204021000},"page":"480-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Physiological roles of \u03b1-synuclein serine-129 phosphorylation \u2013 not an oxymoron"],"prefix":"10.1016","volume":"47","author":[{"given":"Nagendran","family":"Ramalingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-0107","authenticated-orcid":false,"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2024.05.005_bb0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev-pathol-031920-092547","article-title":"The membrane interactions of synuclein: physiology and pathology","volume":"16","author":"Runwal","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.tins.2024.05.005_bb0010","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.05.005_bb0020","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1523\/JNEUROSCI.4787-13.2014","article-title":"Synucleins regulate the kinetics of synaptic vesicle endocytosis","volume":"34","author":"Vargas","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0025","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.cub.2014.08.027","article-title":"\u03b1-synuclein multimers cluster synaptic vesicles and attenuate recycling","volume":"24","author":"Wang","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tins.2024.05.005_bb0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nn.4529","article-title":"\u03b1-Synuclein promotes dilation of the exocytotic fusion pore","volume":"20","author":"Logan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0035","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burr\u00e9","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.tins.2024.05.005_bb0040","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1074\/jbc.M401076200","article-title":"Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study","volume":"279","author":"Nuscher","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0045","doi-asserted-by":"crossref","first-page":"32701","DOI":"10.1073\/pnas.2013652117","article-title":"A dual role for \u03b1-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo","volume":"117","author":"Somayaji","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2024.05.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2024.05.005_bb0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mds.25486","article-title":"Parkin disease and the Lewy body conundrum","volume":"28","author":"Doherty","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2024.05.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104876","article-title":"Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports","volume":"141","author":"Lashuel","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2024.05.005_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","article-title":"Parkinson\u2019s disease: proteinopathy or lipidopathy?","volume":"6","author":"Fanning","year":"2020","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.tins.2024.05.005_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.tins.2024.05.005_bb0075","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0080","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bpa.12845","article-title":"Investigating the presence of doubly phosphorylated \u03b1-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases","volume":"30","author":"Fayyad","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tins.2024.05.005_bb0085","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1091\/mbc.e12-12-0903","article-title":"Serine 129 phosphorylation of membrane-associated \u03b1-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner","volume":"24","author":"Hara","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.tins.2024.05.005_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41531-023-00444-w","article-title":"Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity","volume":"9","author":"Ramalingam","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.tins.2024.05.005_bb0095","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","article-title":"Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function","volume":"111","author":"Parra-Rivas","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.05.005_bb0100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson\u2019s disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0105","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0110","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.tins.2024.05.005_bb0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/brainsci11010119","article-title":"Cerebrospinal fluid \u03b1-synuclein species in cognitive and movements disorders","volume":"11","author":"Constantinides","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.tins.2024.05.005_bb0120","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/srep02540","article-title":"A longitudinal study on \u03b1-synuclein in blood plasma as a biomarker for Parkinson\u2019s disease","volume":"3","author":"Foulds","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2024.05.005_bb0125","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3390\/jcm8101601","article-title":"Plasma pS129-\u03b1-synuclein is a surrogate biofluid marker of motor severity and progression in Parkinson\u2019s disease","volume":"8","author":"Lin","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.tins.2024.05.005_bb0130","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fnins.2019.00889","article-title":"Phospho-S129 alpha-synuclein is present in human plasma but not in cerebrospinal fluid as determined by an ultrasensitive immunoassay","volume":"13","author":"Cariulo","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-019-0155-y","article-title":"Erythrocytic \u03b1-synuclein as a potential biomarker for Parkinson\u2019s disease","volume":"8","author":"Tian","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tins.2024.05.005_bb0140","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/acn3.50944","article-title":"\u03b1-Synuclein in blood cells differentiates Parkinson\u2019s disease from healthy controls","volume":"6","author":"Abd Elhadi","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tins.2024.05.005_bb0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/nan.12531","article-title":"Heterogeneity in \u03b1-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer\u2019s disease","volume":"45","author":"Vaikath","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tins.2024.05.005_bb0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00401-023-02657-y","article-title":"Distinct tau and alpha-synuclein molecular signatures in Alzheimer\u2019s disease with and without Lewy bodies and Parkinson\u2019s disease with dementia","volume":"147","author":"van der Gaag","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2024.05.005_bb0155","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acschemneuro.2c00676","article-title":"Development of a novel electrochemiluminescence ELISA for quantification of \u03b1-synuclein phosphorylated at Ser129 in biological samples","volume":"14","author":"Dutta","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41531-022-00388-7","article-title":"Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity","volume":"8","author":"Lashuel","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.tins.2024.05.005_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134899","article-title":"Generation of monoclonal antibodies against phosphorylated \u03b1-Synuclein at serine 129: research tools for synucleinopathies","volume":"725","author":"Fayyad","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2024.05.005_bb0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","article-title":"Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of Lewy-type histopathology in human brains","volume":"240","author":"Walker","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2024.05.005_bb0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2024.05.005_bb0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-011-0815-1","article-title":"Changes in the solubility and phosphorylation of \u03b1-synuclein over the course of Parkinson\u2019s disease","volume":"121","author":"Zhou","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2024.05.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109617119","article-title":"\u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity","volume":"119","author":"Ghanem","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2024.05.005_bb0190","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cells11050906","article-title":"Pathological relevance of post-translationally modified alpha-synuclein (pSer87, pSer129, nTyr39) in idiopathic Parkinson\u2019s disease and multiple system atrophy","volume":"11","author":"Sonustun","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.tins.2024.05.005_bb0195","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357145","article-title":"Dynamic reversibility of \u03b1-synuclein serine-129 phosphorylation is impaired in synucleinopathy models","volume":"24","author":"Ramalingam","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tins.2024.05.005_bb0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/WNR.0000000000001495","article-title":"Role of alpha-synuclein phosphorylation at Serine 129 in methamphetamine-induced neurotoxicity in vitro and in vivo","volume":"31","author":"Ding","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.tins.2024.05.005_bb0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuint.2019.02.016","article-title":"Iron-induced oxidative stress contributes to \u03b1-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2","volume":"125","author":"Wang","year":"2019","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.tins.2024.05.005_bb0210","article-title":"Aggregation inhibits alpha-synuclein dephosphorylation resulting in the observation of pathological enrichment","author":"Choi","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.tins.2024.05.005_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-022-01468-8","article-title":"Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders","volume":"10","author":"Altay","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2024.05.005_bb0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-022-01403-x","article-title":"Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies","volume":"10","author":"Koss","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2024.05.005_bb0225","article-title":"\u03b1-Synuclein seed amplification technology for Parkinson\u2019s disease and related synucleinopathies","volume":"117","author":"Soto","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tins.2024.05.005_bb0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JPD-213085","article-title":"Specific detection of physiological S129 phosphorylated \u03b1-synuclein in tissue using proximity ligation assay","volume":"13","author":"Arlinghaus","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2024.05.005_bb0235","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2009.06191.x","article-title":"Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson\u2019s disease pathogenesis","volume":"110","author":"Chau","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2024.05.005_bb0240","article-title":"Phosphorylation induces distinct alpha-synuclein strain formation","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2024.05.005_bb0245","article-title":"LK6\/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2024.05.005_bb0250","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.1206286109","article-title":"\u03b1-Synuclein disrupts stress signaling by inhibiting polo-like kinase Cdc5\/Plk2","volume":"109","author":"Wang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2024.05.005_bb0255","first-page":"872","article-title":"Phosphorylation does not prompt, nor prevent, the formation of \u03b1-synuclein toxic species in a rat model of Parkinson\u2019s disease","volume":"18","author":"da Silveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.05.005_bb0260","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","article-title":"\u03b1-Synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease","volume":"68","author":"McFarland","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2024.05.005_bb0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2015.03.008","article-title":"Ser129 phosphorylation of endogenous \u03b1-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function","volume":"78","author":"Buck","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2024.05.005_bb0270","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.1074\/jbc.M800747200","article-title":"Phosphorylation at Ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of alpha-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004302","article-title":"Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson\u2019s disease","volume":"10","author":"Tenreiro","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tins.2024.05.005_bb0280","doi-asserted-by":"crossref","first-page":"E3945","DOI":"10.1073\/pnas.1309991110","article-title":"Polo-like kinase 2 regulates selective autophagic \u03b1-synuclein clearance and suppresses its toxicity in vivo","volume":"110","author":"Oueslati","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2024.05.005_bb0285","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M110.141952","article-title":"Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner","volume":"285","author":"Machiya","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.febslet.2004.07.046","article-title":"Phosphorylated alpha-synuclein in normal mouse brain","volume":"572","author":"Hirai","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2024.05.005_bb0295","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuroscience.2011.10.042","article-title":"\u03b1-synuclein phosphorylation and truncation are normal events in the adult human brain","volume":"200","author":"Muntan\u00e9","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2024.05.005_bb0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41531-023-00491-3","article-title":"Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis","volume":"9","author":"Killinger","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.tins.2024.05.005_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133863","article-title":"Did \u03b1-synuclein and glucocerebrosidase coevolve? Implications for Parkinson\u2019s disease","volume":"10","author":"Gruschus","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2024.05.005_bb0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41531-023-00487-z","article-title":"Synuclein phosphorylation: pathogenic or physiologic?","volume":"9","author":"Kontaxi","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.tins.2024.05.005_bb0315","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1006\/jmbi.2001.5269","article-title":"Defective membrane interactions of familial Parkinson\u2019s disease mutant A30P alpha-synuclein","volume":"315","author":"Jo","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tins.2024.05.005_bb0320","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel Parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells","volume":"23","author":"Fares","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2024.05.005_bb0325","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1523\/JNEUROSCI.1881-21.2022","article-title":"Pathogenic mechanisms of cytosolic and membrane-enriched \u03b1-synuclein converge on fatty acid homeostasis","volume":"42","author":"Tripathi","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100271","article-title":"Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons","volume":"296","author":"Ramalingam","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0335","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neuron.2018.09.014","article-title":"Abrogating native \u03b1-synuclein tetramers in mice causes a L-DOPA-responsive motor syndrome closely resembling Parkinson\u2019s disease","volume":"100","author":"Nuber","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.05.005_bb0340","doi-asserted-by":"crossref","first-page":"20760","DOI":"10.1073\/pnas.1903216116","article-title":"Cell models of lipid-rich \u03b1-synuclein aggregation validate known modifiers of \u03b1-synuclein biology and identify stearoyl-CoA desaturase","volume":"116","author":"Imberdis","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2024.05.005_bb0345","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/1873-3468.14773","article-title":"Adding hydrophobicity or positive charges to the cytosolic half of the \u03b1-synuclein 3-11 helix increases membrane association and S129 phosphorylation","volume":"598","author":"Shimanaka","year":"2023","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tins.2024.05.005_bb0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0166-4328(95)00216-2","article-title":"Psychobiology of plasticity: effects of training and experience on brain and behavior","volume":"78","author":"Rosenzweig","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.tins.2024.05.005_bb0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/35044558","article-title":"Neural consequences of environmental enrichment","volume":"1","author":"van Praag","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tins.2024.05.005_bb0360","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.E23-07-0269","article-title":"Excess phosphoserine-129 \u03b1-synuclein induces synaptic vesicle trafficking and declustering defects at a vertebrate synapse","volume":"35","author":"Wallace","year":"2024","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.tins.2024.05.005_bb0365","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1074\/mcp.M800116-MCP200","article-title":"Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions","volume":"7","author":"McFarland","year":"2008","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.tins.2024.05.005_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102239","article-title":"Molecular and functional interactions of alpha-synuclein with Rab3a","volume":"298","author":"Lv","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.05.005_bb0375","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-023-00680-x","article-title":"\u03b1-Synuclein serine129 phosphorylation - the physiology of pathology","volume":"18","author":"Ramalingam","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2024.05.005_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.50","article-title":"Increased \u03b1-synuclein phosphorylation and nitration in the aging primate substantia nigra","volume":"3","author":"McCormack","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tins.2024.05.005_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252635","article-title":"Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein","volume":"16","author":"Elfarrash","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2024.05.005_bb0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JPD-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.tins.2024.05.005_bb0395","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2024.0792","article-title":"Skin biopsy detection of phosphorylated \u03b1-synuclein in patients with synucleinopathies","volume":"331","author":"Gibbons","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.tins.2024.05.005_bb0400","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of \u03b1-synuclein","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2024.05.005_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166961","article-title":"Synapsin condensates recruit alpha-synuclein","volume":"433","author":"Hoffmann","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tins.2024.05.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101552","article-title":"Phosphorylation of the aggregate-forming protein alpha-synuclein on serine-129 inhibits its DNA-bending properties","volume":"298","author":"Dent","year":"2022","journal-title":"J. Biol. Chem."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223624000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223624000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T01:43:07Z","timestamp":1786066987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223624000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0166223624000857"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2024.05.005","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiological roles of \u03b1-synuclein serine-129 phosphorylation \u2013 not an oxymoron","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2024.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}